Antiemetic Use During Pregnancy

Project Title	Antiemetic Use During Pregnancy
Date Posted	Monday, June 24, 2019
Project ID	to07_add_preg_ahr_wp008
Status	Complete
Deliverables	Mini-Sentinel Modular Program Report: Antiemetic Use During Pregnancy
Related Links	Antiemetic Use Among Pregnant Women in the United States: The Escalating Use of Ondansetron 2016 ICPE Presentation: Ondasetron Use Among Pregnancies Identified in the Sentinel Distributed Database
Description	This report contains the prevalence of antiemetic use among women of reproductive age who delivered a liveborn infant in the Mini-Sentinel Distributed Database (MSDD). Results for antiemetic use are also presented for a matched comparator cohort with no live-birth deliveries during the request period. Data from January 1, 2001 to December 31, 2014 from 15 Data Partners contributing to the MSDD were included in this report. This request was distributed to Data Partners on November 10, 2015.
Medical Product	doxylamine granisetron metoclopramide HCL netupitant/palonosetron HCl ondansetron palonosetron prochlorperazine promethazine HCl succinate/pyridoxine HCl
Health Outcome	exposure in pregnancy
Population / Cohort	Females 0 to 54 years of age
Time Period	January 1, 2001 to December 31, 2014
Assessment Type	Exploratory Analyses
Study Type	Modular Program
Data Sources	Mini-Sentinel Distributed Database (MSDD)
FDA Center	CDER

Search form